from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3678c/-

LFCtreatmentdescriptionclass of inhibitor

-0.267

Amikacinug/mL Amikacintranslation

-0.667

Cap5-10ug/mL Capreomycintranslation

-0.805

Rox10-50 ug/mL Roxithromycintranslation

0.491

SM2-5 ug/mL Streptomycintranslation

0.785

Tet5-10 ug/mL Tetracyclinetranslation

0.928

Rif0.2-5ug/mL Rifampicintranscription

-0.511

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.370

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.604

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.689

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.338

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.245

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.158

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.380

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.478

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.174

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.052

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.890

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.015

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.266

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.412

KCN5-20 ug/mL Potassium cyaniderespiration

0.716

NaN30.2-2 mM Sodium aziderespiration

0.052

Nigericin50 uM Nigericinrespiration

-0.767

TRC10-150 ug/mL Triclosanrespiration

-1.862

TRZ10-25 ug/mL Thioridazinerespiration

-2.585

Valinomycin0.5-10 uM Valinomycinrespiration

0.533

ZnSO42 mM ZnSO4respiration

-0.266

menadione6-10 ug/mL Menadionerespiration

-0.100

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.172

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.365

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.255

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.448

NRP_1Non-replicating persistence stage 1dosRassociated

0.618

Amp0.2mg/mL AmpicillincellWall

-0.075

Cephalexin20-100 ug/mL CephalexincellWall

-0.167

Cerulenin0.32-5 ug/mL CerulenincellWall

0.856

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.662

EMB10-20 ug/mL EthambutolcellWall

0.877

Eta12-40 ug/mL EthionamidecellWall

1.393

INH0.2-0.4 ug/mL IsoniazidcellWall

1.056

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.461

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.787

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.121

BZA0.12 mg/mL BenzamidearomaticAmides

0.324

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.439

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.756

H2O24 mM hydrogen peroxideDNAdamaging

0.154

Levo10 ug/mL LevofloxacinDNAdamaging

0.904

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.090

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.651

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.768

UVUV-irradiationDNAdamaging

-1.217

ARP41-4 ug/mL Antitubercular compound ARP4?

0.262

Antimycin12.5-50 ug/mL Antimycin A?

0.289

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.530

PA_110-50 ug/mL Antitubercular compound PA-1?

0.307

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.281

PA8240.2-2 ug/mL PA-824?

0.064

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.634

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.020

Verapamil50 uM Verapamil?

0.130

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.443

methoxatin10-20 ug/mL Methoxatin?